Lee Jae Hyup, Kim Jungju, Baek Hae-Ri, Lee Kyung Mee, Seo Jun-Hyuk, Lee Hyun-Kyung, Lee A-Young, Zheng Guang Bin, Chang Bong-Soon, Lee Choon-Ki
Department of Orthopedic Surgery, College of Medicine, SMG-SNU Boramae Medical Center, Seoul National University, 425 Shindaebang-2-Dong, Seoul, 156-707, Korea,
J Mater Sci Mater Med. 2014 Sep;25(9):2141-51. doi: 10.1007/s10856-014-5250-0. Epub 2014 Jun 14.
Methods to improve osseointegration that include implantation of rhBMP-2 with various kinds of carriers are currently of considerable interest. The present study was conducted to evaluate if the rhBMP-2 loaded β-TCP microsphere-hyaluronic acid-based powder-like hydrogel composite (powder gel) can act as an effective rhBMP-2 carrier for implantation in host bone with a bone defect or poor bone quality. The release pattern for rhBMP-2 was then evaluated against an rhBMP-2-loaded collagen sponge as a control group. Dental implants were also inserted into the tibias of three groups of rabbits: an rhBMP-2 (200 µg) loaded powder gel composite implanted group, an implant only group, and a powder gel implanted group. Micro-CT and histology of the implanted areas were carried out four weeks later. The rhBMP-2 powder gel released less rhBMP-2 than the collagen sponge, but it continued a slow release for more than 7 days. The rhBMP-2 powder gel composite improved osseointegration of the dental implant by increasing the amount of new bone formation in the implant pitch and it improved the bone quality and bone quantity of new bone. The histology results indicated that the rhBMP-2 powder gel composite improved the osseointegration in the cortical bone as well as the marrow space along the fixture. The bone-to-implant contact ratio of the rhBMP-2 (200 µg) loaded powder gel composite implanted group was significantly higher than those of the implant only group and the powder gel implanted group. The powder gel appeared to be a good carrier and could release rhBMP-2 slowly to promote the formation of new bone following implantation in a bone defect, thereby improving implant osseointegration.
目前,包括将重组人骨形态发生蛋白-2(rhBMP-2)与各种载体一起植入在内的改善骨整合的方法备受关注。本研究旨在评估负载rhBMP-2的β-磷酸三钙微球-透明质酸基粉末状水凝胶复合材料(粉末凝胶)是否能作为一种有效的rhBMP-2载体,用于植入有骨缺损或骨质量差的宿主骨中。然后,以负载rhBMP-2的胶原海绵作为对照组,评估rhBMP-2的释放模式。还将牙种植体植入三组兔子的胫骨中:植入负载rhBMP-2(200μg)的粉末凝胶复合材料组、仅植入种植体组和植入粉末凝胶组。四周后对植入区域进行显微CT和组织学检查。rhBMP-2粉末凝胶释放的rhBMP-2比胶原海绵少,但它持续缓慢释放超过7天。rhBMP-2粉末凝胶复合材料通过增加种植体间隙中新骨形成的量来改善牙种植体的骨整合,并改善了新骨的骨质量和骨量。组织学结果表明,rhBMP-2粉末凝胶复合材料改善了皮质骨以及沿固定装置的骨髓腔中的骨整合。负载rhBMP-2(200μg)的粉末凝胶复合材料植入组的骨与种植体接触率明显高于仅植入种植体组和植入粉末凝胶组。粉末凝胶似乎是一种良好的载体,在植入骨缺损后能缓慢释放rhBMP-2以促进新骨形成,从而改善种植体骨整合。